A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial
Top Cited Papers
- 14 September 2014
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 385 (9962), 43-54
- https://doi.org/10.1016/s0140-6736(14)61455-0
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular ScaffoldCirculation: Cardiovascular Interventions, 2012
- From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?European Heart Journal, 2011
- Bioresorbable Polymeric Vascular ScaffoldsCirculation: Cardiovascular Interventions, 2011
- Angiographic Geometric Changes of the Lumen Arterial Wall After Bioresorbable Vascular Scaffolds and Metallic Platform Stents at 1-Year Follow-UpJACC: Cardiovascular Interventions, 2011
- The Pathology of Neoatherosclerosis in Human Coronary ImplantsJournal of the American College of Cardiology, 2011
- Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery StenosisCirculation, 2010
- Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery ModelCirculation, 2010
- Optimal Medical Therapy with or without PCI for Stable Coronary DiseaseNew England Journal of Medicine, 2007
- Guidelines on the management of stable angina pectorisEuropean Heart Journal, 2006
- ACC/AHA 2002 Guideline Update for Exercise Testing: Summary ArticleCirculation, 2002